Clinical and biological significance of tissue transglutaminase in ovarian carcinoma. - Wikidata - wikimedia - TriplyDB

Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.

Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.

http://www.wikidata.org/entity/Q30483685

about

Transglutaminase-2 interaction with heparin: identification of a heparin binding site that regulates cell adhesion to fibronectin-transglutaminase-2 matrix Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death Transglutaminase is a tumor cell and cancer stem cell survival factor Tissue transglutaminase as a central mediator in inflammation-induced progression of breast cancer Enzymatically Regulated Peptide Pairing and Catalysis for the Bioanalysis of Extracellular Prometastatic Activities of Functionally Linked Enzymes Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells.Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs Conformational changes and translocation of tissue-transglutaminase to the plasma membranes: role in cancer cell migration.Transglutaminase regulation of cell function.Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism.Ovarian cancer development and metastasis.TGM2: a cell surface marker in esophageal adenocarcinomas.Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma.Tissue transglutaminase constitutively activates HIF-1α promoter and nuclear factor-κB via a non-canonical pathway.Transglutaminase 2 overexpression in tumor stroma identifies invasive ductal carcinomas of breast at high risk of recurrence.Chitosan hydrogel for localized gene silencing Silencing survivin splice variant 2B leads to antitumor activity in taxane--resistant ovarian cancer Role of tissue transglutaminase 2 in the acquisition of a mesenchymal-like phenotype in highly invasive A431 tumor cells.Transglutaminase 2 expression and its prognostic significance in clear cell renal cell carcinoma.Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer.Transglutaminase 2 facilitates the distant hematogenous metastasis of breast cancer by modulating interleukin-6 in cancer cells.Silencing of TGM2 reverses epithelial to mesenchymal transition and modulates the chemosensitivity of breast cancer to docetaxel.Diagnosis and management of peritoneal metastases from ovarian cancer.Evidence that GTP-binding domain but not catalytic domain of transglutaminase 2 is essential for epithelial-to-mesenchymal transition in mammary epithelial cells.Tissue transglutaminase-interleukin-6 axis facilitates peritoneal tumor spreading and metastasis of human ovarian cancer cells.R(h)oads to microvesicles Extracellular tissue transglutaminase activates noncanonical NF-κB signaling and promotes metastasis in ovarian cancer A serum based analysis of ovarian epithelial tumorigenesis Tissue transglutaminase is an essential participant in the epidermal growth factor-stimulated signaling pathway leading to cancer cell migration and invasion Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity Surgical stress promotes tumor growth in ovarian carcinoma.Tissue transglutaminase, inflammation, and cancer: how intimate is the relationship?Tissue Transglutaminase (TG2)-Induced Inflammation in Initiation, Progression, and Pathogenesis of Pancreatic Cancer.A novel mechanism by which tissue transglutaminase activates signaling events that promote cell survival.Tissue transglutaminase induces Epithelial-Mesenchymal-Transition and the acquisition of stem cell like characteristics in colorectal cancer cells miR-19-Mediated Inhibition of Transglutaminase-2 Leads to Enhanced Invasion and Metastasis in Colorectal Cancer.Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target.Transglutaminase 2 reprogramming of glucose metabolism in mammary epithelial cells via activation of inflammatory signaling pathways.Transglutaminase 2 expression in acute myeloid leukemia: association with adhesion molecule expression and leukemic blast motility.Expression of transglutaminase-2 isoforms in normal human tissues and cancer cell lines: dysregulation of alternative splicing in cancer.

P2860

Q24309155-203F3B9F-2C87-45C4-971B-550D74D76398 Q24632721-CFD472F0-9A4D-4DDC-9C64-52F0C16556D5 Q26799862-058B1DE7-0899-4386-8956-EB699E782EC5 Q26824316-61AEFAE0-621F-4492-B639-7BB5FD2F86E6 Q27317379-F572632D-9B67-4F47-B454-A8F49ECBFCB7 Q30499127-07806B07-ADDF-49BA-824E-8E8F4E4A5D41 Q30844815-CC5881FA-AD82-45AF-A4FD-4680393171DF Q33611930-18AB2D45-5ADB-43D4-B7E2-DE50C1EBBD61 Q33707936-9D8AA1D1-2D60-4429-85F3-8CBBF96D1806 Q33730021-0AF34BC2-EA84-46DC-AF55-E0C5B57A2619 Q34086819-4C50283E-BE85-4855-9AA5-CC905844E5D4 Q34219975-2D7D5E90-E25C-4C94-B3EA-CDE67F689625 Q34251059-26BD4771-16A7-44AF-8F19-28EC091F4B93 Q34489967-184F03C5-0B3E-4FF1-885B-2987DE5590A7 Q34994693-7E2CF2EF-A67D-4BC8-A843-A53166E40341 Q35001428-3CC3956E-C401-4662-BCD1-C1CAB93302AF Q35024933-E3C67969-24AC-4FED-AC0A-68A867C261FA Q35147626-A015416B-C9F0-4D59-A476-EE9B29758E0E Q35170748-1E873EB4-23D6-43F0-A795-4CBDA8513DF2 Q35387117-43503BB5-980E-4D68-B7CF-74605976FC71 Q35683575-4AC9FBE1-A432-4549-8BCF-F22CA9956A21 Q36081102-22C36F9B-0464-4325-AAC8-074173B7E7B0 Q36128985-CC2F1366-00A1-4D4B-9AE3-4463528E59E5 Q36393086-72BE43C2-77F7-43A3-9BD6-3737C8037695 Q36447849-082F0B2F-C023-48B2-945D-B395A08F1E50 Q36463007-ABAD5373-665F-4119-95C7-451EAB50313B Q36879220-FB8E8E4E-3C27-4DC8-A5F0-86F3EB30C896 Q37133800-866A5BD8-2F4A-4197-9033-119E258B38D5 Q37258496-66A9E3AF-05E1-4E1D-9CE7-5A461ACF8922 Q37286656-B04C1538-C408-4623-8461-AD7FF1DD94CD Q37353385-3B4F88F1-E761-4FD3-B8CB-547539BEECD8 Q37956221-B6FC8585-8E0B-4877-ADEA-5F930906B277 Q38161340-1B94C922-F17B-4100-ACEA-C710F8B03D72 Q38608634-1A5C2EBC-FAE0-4C15-BD0D-FB78F0E5CEBC Q38715434-21D7DD2C-4253-4024-A04A-272E0EE1CFF0 Q38879949-FD5376CC-DEBB-4AA2-9C0B-67FB7EDB735E Q38937553-6C960EA2-F297-4917-AC4F-1B6446577561 Q39029196-2DE46A96-7222-45E8-93C8-0E17474C87AC Q39168249-F25D7E96-38A7-4680-8DEB-CFAC365DBFB2 Q39442011-5BE68FE2-2646-42AD-A78F-304BCFAEBE82

P2860

Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.

http://www.wikidata.org/entity/Q30483685

description

2008 nî lūn-bûn

@nan

2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.

@ast

Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.

@en

type

label

Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.

@ast

Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.

@en

prefLabel

Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.

@ast

Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.

@en

P1433

Q30483685-FA434E42-8E13-429A-9471-C03E2CA21F4B

P1476

Q30483685-6517DC17-D47F-4DBA-9DA5-49409A4D1C7F

P2093

Q30483685-05A9F4A4-25F2-4893-AFCD-9DDE5BD231FA

Q30483685-19BF8A64-597E-436E-86C2-45A1C4FA878D

Q30483685-1AA7BA7A-5EF5-44FE-B3C3-03E40EC28489

Q30483685-26EAF70E-670B-493A-ADD6-FF06F680616C

Q30483685-43AF34D8-E973-4762-BA26-C7A94339E9EB

Q30483685-5048C43A-A04A-4B27-B43B-FB893ECA7E08

Q30483685-5D8ABBDC-ABC9-4CEB-A0BE-80F934FBA2DF

Q30483685-63CCC49F-D3C1-47E8-B1A1-35B7FB0CE75F

Q30483685-76F3371A-019F-4499-AA7F-BCBF9EBB2CC8

Q30483685-89648F6E-3B7B-4EA8-83ED-5D01D482AAD0

P2860

Q30483685-00BE2B45-F76E-4D4E-9FCC-2DFF569A9F74

Q30483685-0529B2E9-977E-4DDD-B5A8-63E361EF3418

Q30483685-0843380B-479F-43E2-959B-26C06FA57C16

Q30483685-097BBBD7-0F9F-4035-94A2-3F3F1983328D

Q30483685-0C4839CD-D99A-4AB1-AE1A-6D28B1E7D924

Q30483685-1D30DFA4-7E68-43F2-B1FC-E8A73545051C

Q30483685-2622AE02-4177-4B60-8E17-178F29B5D3D9

Q30483685-3F9019C0-F7F4-474E-A9D6-8DEFE4183778

Q30483685-42DF9522-9A59-451E-A2FD-EB77C6EB738B

Q30483685-45F0F124-52B0-4D63-AEA4-AFEBCB0A6A74

P304

Q30483685-89B64D94-6F42-43CF-A280-5D108F89EF58

P31

Q30483685-86DAD34F-5A99-46B5-BD2D-0641C3146DA1

P356

Q30483685-0B51829B-0EB4-4F1C-8D2A-7F56C86E7A56

P407

Q30483685-7D8C9043-48B4-4F6B-8A6A-19A848232388

P433

Q30483685-DC21543B-AAF1-4259-B443-C58E12B662FA

P478

Q30483685-F44BCAA8-95CA-4F0E-AAFE-F80DA8CABE88

P577

Q30483685-59178002-375F-437B-980A-034EF0592696

P5875

Q30483685-3BEBEA9C-0557-419D-97B9-2A8CE9E7F308

P698

Q30483685-57CB6FD0-A4E1-4AAF-8207-2DF31B580D07

P932

Q30483685-238D64CB-6BF3-4C3B-BD92-31CA539DB013

P356

0008-5472.CAN-07-6130

P1433

Cancer Research

P1476

Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.

@en

P2093

Alpa M Nick

http://www.w3.org/2001/XMLSchema#string

Anil K Sood

http://www.w3.org/2001/XMLSchema#string

Derek J Fiterman

http://www.w3.org/2001/XMLSchema#string

Gabriel Lopez-Berestein

http://www.w3.org/2001/XMLSchema#string

Jansina Y Fok

http://www.w3.org/2001/XMLSchema#string

Jee Young Hwang

http://www.w3.org/2001/XMLSchema#string

Kapil Mehta

http://www.w3.org/2001/XMLSchema#string

Lingegowda S Mangala

http://www.w3.org/2001/XMLSchema#string

Michael T Deavers

http://www.w3.org/2001/XMLSchema#string

Pablo E Vivas-Mejia

http://www.w3.org/2001/XMLSchema#string

P2860

Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway

The nuclear factor kappa B inhibitor parthenolide restores ICI 182,780 (Faslodex; fulvestrant)-induced apoptosis in antiestrogen-resistant breast cancer cells.

Transglutaminase 2: an enigmatic enzyme with diverse functions

Biochemical signals and biological responses elicited by the focal adhesion kinase

Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase

Transglutaminase 2 induces nuclear factor-kappaB activation via a novel pathway in BV-2 microglia

Cancer statistics, 2007

Phospholipase Cdelta1 is a guanine nucleotide exchanging factor for transglutaminase II (Galpha h) and promotes alpha 1B-adrenoreceptor-mediated GTP binding and intracellular calcium release.

Role of tissue transglutaminase in celiac disease.

Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases.

P304

5849-5858

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-07-6130

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51407223

http://www.w3.org/2001/XMLSchema#string

P698

18632639

http://www.w3.org/2001/XMLSchema#string

P932

2547344

http://www.w3.org/2001/XMLSchema#string